nach oben

Erschienen in:

01.12.2013 | Original Article

Association study of the estrogen receptor gene ESR1 with postpartum depression—a pilot study

verfasst von: Julia K. Pinsonneault, Danielle Sullivan, Wolfgang Sadee, Claudio N. Soares, Elizabeth Hampson, Meir Steiner

Erschienen in: Archives of Women's Mental Health | Ausgabe 6/2013

Einloggen, um Zugang zu erhalten

Abstract

Perinatal mood disorders, such as postpartum depression (PPD), are costly for society, with potentially serious consequences for mother and child. While multiple genes appear to play a role in PPD susceptibility, the contributions of specific genetic variations remain unclear. Previously implicated as a candidate gene, the estrogen receptor alpha gene (ESR1) is a key player in mediating hormonal differences during pregnancy and the postpartum period. This study addresses genetic factors in perinatal mood disorders, testing nine polymorphisms in ESR1. Two hundred fifty-seven postpartum women were screened for mood disorders, including 52 women with PPD and 32 without any symptoms of mood disorders. We detected a significant association for the upstream TA microsatellite repeat with Edinburgh Postnatal Depression Scale scores (p = 0.007). The same variant was also associated with the occurrence of PPD. Separately, 11 candidate functional polymorphisms in 7 additional genes were genotyped to investigate gene–gene interaction with the ESR1 TA repeat, identifying a potential interaction with the serotonin transporter. Our results support a role for ESR1 in the etiology of PPD, possibly through the modulation of serotonin signaling. Our findings for ESR1 could have broad implications for other disorders and therapies that involve estrogens.

Nur mit Berechtigung zugänglich

Ahokas A, Aito M, Rimon R (2000) Positive treatment effect of estradiol in postpartum psychosis: a pilot study. J Clin Psychiatry 61:166–169PubMedCrossRef

Albrecht E, Pepe G (1990) Placental steroid hormone biosynthesis in primate pregnancy. Endocrinol Rev 11:124–150CrossRef

Amin Z, Mason GF, Cavus I, Krystal JH, Rothman DL, Epperson CN (2006) The interaction of neuroactive steroids and GABA in the development of neuropsychiatric disorders in women. Pharmacol Biochem Behav 84(4):635–643PubMedCrossRef

Anghel A, Narita D, Seclaman E, Popovici E, Anghel M, Tamas L (2010) Estrogen receptor alpha polymorphisms and the risk of malignancies. Pathol Oncol Res 16(4):485–496. doi:10.1007/s12253-010-9263-9 PubMedCrossRef

Anguelova M, Benkelfat C, Turecki G (2003a) A systematic review of association studies investigating genes coding for serotonin receptors and the serotonin transporter: I. Affective disorders. Mol Psychiatry 8(6):574–591PubMedCrossRef

Anguelova M, Benkelfat C, Turecki G (2003b) A systematic review of association studies investigating genes coding for serotonin receptors and the serotonin transporter: II. Suicidal behavior. Mol Psychiatry 8(7):646–653PubMedCrossRef

Bell A, Land N, Milne S, Hassanyeh F (1994) Long-term outcome of post-partum psychiatric illness requiring admission. J Affect Disord 31:67–70PubMedCrossRef

Bellivier F, Szoke A, Henry C, Lacoste J, Bottos C, Nosten-Bertrand M, Hardy P, Rouillon F, Launay JM, Laplanche JL, Leboyer M (2000) Possible association between serotonin transporter gene polymorphism and violent suicidal behavior in mood disorders. Biol Psychiatry 48(4):319–322PubMedCrossRef

Bethea CL, Lu NZ, Gundlah C, Streicher JM (2002) Diverse actions of ovarian steroids in the serotonin neural system. Front Neuroendocrinol 23(1):41–100. doi:10.1006/frne.2001.0225 PubMedCrossRef

Beyer C, Pawlak J, Karolczak M (2003) Membrane receptors for oestrogen in the brain. J Neurochem 87:545–550PubMedCrossRef

Binder EB, Jeffrey Newport D, Zach EB, Smith AK, Deveau TC, Altshuler LL, Cohen LS, Stowe ZN, Cubells JF (2010) A serotonin transporter gene polymorphism predicts peripartum depressive symptoms in an at-risk psychiatric cohort. J Psychiatr Res 44(10):640–646. doi:10.1016/j.jpsychires.2009.12.001 PubMedCrossRef

Bloch M, Schmidt P, Danaceau M, Murphy J, Nieman L, Rubinow D (2000) Effects of gonadal steroids in women with a history of postpartum depression. Am J Psychiatry 157:924–930PubMedCrossRef

Caspi A, Sugden K, Moffitt T, Taylor A, Craig I, Harrington H, McClay J, Mill J, Martin J, Braithwaite A, Poulton R (2003a) Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301:386–389PubMedCrossRef

Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, McClay J, Mill J, Martin J, Braithwaite A, Poulton R (2003b) Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301(5631):386–389PubMedCrossRef

Cervilla JA, Rivera M, Molina E, Torres-Gonzalez F, Bellon JA, Moreno B, de Dios LJ, Lorente JA, de Diego-Otero Y, King M, Nazareth I, Gutierrez B (2006) The 5-HTTLPR s/s genotype at the serotonin transporter gene (SLC6A4) increases the risk for depression in a large cohort of primary care attendees: the PREDICT-gene study. Am J Med Genet B Neuropsychiatr Genet 141B(8):912–917PubMedCrossRef

Chaudhury D, Walsh JJ, Friedman AK, Juarez B, Ku SM, Koo JW, Ferguson D, Tsai HC, Pomeranz L, Christoffel DJ, Nectow AR, Ekstrand M, Domingos A, Mazei-Robison MS, Mouzon E, Lobo MK, Neve RL, Friedman JM, Russo SJ, Deisseroth K, Nestler EJ, Han MH (2013) Rapid regulation of depression-related behaviours by control of midbrain dopamine neurons. Nature 493(7433):532–536. doi:10.1038/nature11713 PubMedCrossRef

Comings D, Muhleman D, Johnson P, MacMurray J (1999) Potential role of the estrogen receptor gene (ESR1) in anxiety. Mol Psychiatr 4(4):374–377CrossRef

Costas J, Gratacos M, Escaramis G, Martin-Santos R, de Diego Y, Baca-Garcia E, Canellas F, Estivill X, Guillamat R, Guitart M, Gutierrez-Zotes A, Garcia-Esteve L, Mayoral F, Molto MD, Phillips C, Roca M, Carracedo A, Vilella E, Sanjuan J (2010) Association study of 44 candidate genes with depressive and anxiety symptoms in post-partum women. J Psychiatr Res 44(11):717–724. doi:10.1016/j.jpsychires.2009.12.012 PubMedCrossRef

Cox J, Holden J, Sagovsky R (1987) Detection of postnatal depression: Development of the 10-item Edinburgh Postnatal depression scale. Br J Psychiatry 150:782–786PubMedCrossRef

Deecher D, Andree TH, Sloan D, Schechter LE (2008) From menarche to menopause: exploring the underlying biology of depression in women experiencing hormonal changes. Psychoneuroendocrinology 33(1):3–17PubMedCrossRef

Domschke K, Dannlowski U, Ohrmann P, Lawford B, Bauer J, Kugel H, Heindel W, Young R, Morris P, Arolt V, Deckert J, Suslow T, Baune BT (2008) Cannabinoid receptor 1 (CNR1) gene: impact on antidepressant treatment response and emotion processing in major depression. Eur Neuropsychopharmacol 18(10):751–759PubMedCrossRef

Doornbos B, Dijck-Brouwer DA, Kema IP, Tanke MA, van Goor SA, Muskiet FA, Korf J (2009) The development of peripartum depressive symptoms is associated with gene polymorphisms of MAOA, 5-HTT and COMT. Prog Neuropsychopharmacol Biol Psychiatry 33(7):1250–1254. doi:10.1016/j.pnpbp.2009.07.013 PubMedCrossRef

Epperson CN, Gueorguieva R, Czarkowski KA, Stiklus S, Sellers E, Krystal JH, Rothman DL, Mason GF (2006) Preliminary evidence of reduced occipital GABA concentrations in puerperal women: a 1H-MRS study. Psychopharmacology (Berlin) 186(3):425–433CrossRef

Figueira P, Malloy-Diniz L, Campos SB, Miranda DM, Romano-Silva MA, De Marco L, Neves FS, Correa H (2010) An association study between the Val66Met polymorphism of the BDNF gene and postpartum depression. Arch Womens Ment Health 13(3):285–289. doi:10.1007/s00737-010-0146-6 PubMedCrossRef

Fink G, Sumner BE, McQueen JK, Wilson H, Rosie R (1998) Sex steroid control of mood, mental state and memory. Clin Exp Pharmacol Physiol 25(10):764–775PubMedCrossRef

Forty L, Jones L, Macgregor S, Caesar S, Cooper C, Hough A, Dean L, Dave S, Farmer A, McGuffin P, Brewster S, Craddock N, Jones I (2006) Familiality of postpartum depression in unipolar disorder: results of a family study. Am J Psychiatry 163(9):1549–1553PubMedCrossRef

Gade-Andavolu R, Macmurray J, Comings DE, Calati R, Chiesa A, Serretti A (2009) Association between the estrogen receptor TA polymorphism and Harm avoidance. Neurosci Lett 467(2):155–158. doi:10.1016/j.neulet.2009.10.028 PubMedCrossRef

Halbreich U, Rojansky N, Palter S, Tworek H, Hissin P, Wang K (1995) Estrogen augments serotonergic activity in postmenopausal women. Biol Psychiatry 37(7):434–441. doi:10.1016/0006-3223(94)00181-2 PubMedCrossRef

Heils A, Teufel A, Petri S, Stober G, Riederer P, Bengel D, Lesch KP (1996) Allelic variation of human serotonin transporter gene expression. J Neurochem 66(6):2621–2624PubMedCrossRef

Kugaya A, Epperson CN, Zoghbi S, van Dyck CH, Hou Y, Fujita M, Staley JK, Garg PK, Seibyl JP, Innis RB (2003) Increase in prefrontal cortex serotonin 2A receptors following estrogen treatment in postmenopausal women. Am J Psychiatry 160(8):1522–1524PubMedCrossRef

Kunnas TA, Holmberg-Marttila D, Karhunen PJ (1999) Analysis of estrogen receptor dinucleotide polymorphism by capillary gel electrophoresis with a population genetic study in 180 Finns. Hum Hered 49(3):142–145PubMedCrossRef

Lazinski M, Shea A, Steiner M (2008) Effects of maternal stress on offspring development. Arch Womens Ment Health 11:363–375PubMedCrossRef

Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, Benjamin J, Muller CR, Hamer DH, Murphy DL (1996) Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274(5292):1527–1531PubMedCrossRef

Lim J, Papp A, Pinsonneault J, Sadee W, Saffen D (2006) Allelic expression of serotonin transporter (SERT) mRNA in human pons: lack of correlation with the polymorphism SERTLPR. Mol Psychiatry 11:649–662PubMedCrossRef

Lim J, Pinsonneault J, Sadee W, Saffen D (2007) Tryptophan hydroxylase 2 (TPH2) haplotypes predict levels of TPH2 mRNA expression in human pons. Mol Psychiatry 12(5):491–501PubMed

Lokuge S, Frey B, Foster J, Soares C, Steiner M (2011a) Neurobiological basis of depression in women: new insights into the link between estrogen and serotonin. J Clin Psychiatry 72:e1563–e1569PubMedCrossRef

Lokuge S, Frey BN, Foster JA, Soares CN, Steiner M (2010) The rapid effects of estrogen: a mini-review. Behav Pharmacol 21(5–6):465–472. doi:10.1097/FBP.0b013e32833da5c3 PubMedCrossRef

Lokuge S, Frey BN, Foster JA, Soares CN, Steiner M (2011b) Depression in women: windows of vulnerability and new insights into the link between estrogen and serotonin. J Clin Psychiatry 72(11):e1563–1569. doi:10.4088/JCP.11com07089

Mahon PB, Payne JL, MacKinnon DF, Mondimore FM, Goes FS, Schweizer B, Jancic D, Coryell WH, Holmans PA, Shi J, Knowles JA, Scheftner WA, Weissman MM, Levinson DF, DePaulo JR Jr, Zandi PP, Potash JB (2009) Genome-wide linkage and follow-up association study of postpartum mood symptoms. Am J Psychiatry 166(11):1229–1237. doi:10.1176/appi.ajp.2009.09030417 PubMedCrossRef

McEwen B (2001) Estrogens effects on the brain: multiple sites and molecular mechanisms. J Appl Physiol 91:2785–2801PubMed

McQueen JK, Wilson H, Fink G (1997) Estradiol-17 beta increases serotonin transporter (SERT) mRNA levels and the density of SERT-binding sites in female rat brain. Brain Res Mol Brain Res 45(1):13–23PubMedCrossRef

McQueen JK, Wilson H, Sumner BE, Fink G (1999) Serotonin transporter (SERT) mRNA and binding site densities in male rat brain affected by sex steroids. Brain Res Mol Brain Res 63(2):241–247PubMedCrossRef

Mehta D, Quast C, Fasching PA, Seifert A, Voigt F, Beckmann MW, Faschingbauer F, Burger P, Ekici AB, Kornhuber J, Binder EB, Goecke TW (2012) The 5-HTTLPR polymorphism modulates the influence on environmental stressors on peripartum depression symptoms. J Affect Disord 136(3):1192–1197. doi:10.1016/j.jad.2011.11.042 PubMedCrossRef

Michopoulos V, Berga SL, Wilson ME (2011) Estradiol and progesterone modify the effects of the serotonin reuptake transporter polymorphism on serotonergic responsivity to citalopram. Exp Clin Psychopharmacol 19(6):401–408. doi:10.1037/a0025008 2011-17877-001 PubMedCrossRef

Mill J, Kiss E, Baji I, Kapornai K, Daróczy G, Vetró A, Kennedy J, Kovacs M, Barr C (2008) Association study of the estrogen receptor alpha gene (ESR1) and childhood-onset mood disorders. Am J Med Genet B Neuropsychiatr Genet 147B:1323–1326PubMedCrossRef

Miller S, Dykes D, Polesky H (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215PubMedCrossRef

Montgomery S, Asberg M (1979) A new depression scale designed to be sensitive to change. Br J Psychiatry 134:382–389PubMedCrossRef

Mrazek DA, Rush AJ, Biernacka JM, O’Kane DJ, Cunningham JM, Wieben ED, Schaid DJ, Drews MS, Courson VL, Snyder KA, Black JL, 3rd, Weinshilboum RM (2008) SLC6A4 variation and citalopram response. Am J Med Genet B Neuropsychiatr Genet

Murphy-Eberenz K, Zandi PP, March D, Crowe RR, Scheftner WA, Alexander M, McInnis MG, Coryell W, Adams P, DePaulo JR Jr, Miller EB, Marta DH, Potash JB, Payne J, Levinson DF (2006) Is perinatal depression familial? J Affect Disord 90(1):49–55PubMedCrossRef

Murphy GM Jr, Hollander SB, Rodrigues HE, Kremer C, Schatzberg AF (2004) Effects of the serotonin transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric major depression. Arch Gen Psychiatry 61(11):1163–1169PubMedCrossRef

Nott P, Franklin M, Armitage C, Gelder M (1976) Hormonal changes and mood in the puerperium. Br J Psychiatry 128:379–383PubMedCrossRef

Payne JL, Roy PS, Murphy-Eberenz K, Weismann MM, Swartz KL, McInnis MG, Nwulia E, Mondimore FM, MacKinnon DF, Miller EB, Nurnberger JI, Levinson DF, DePaulo JR Jr, Potash JB (2007) Reproductive cycle-associated mood symptoms in women with major depression and bipolar disorder. J Affect Disord 99(1–3):221–229PubMedCrossRef

Pecins-Thompson M, Brown NA, Bethea CL (1998) Regulation of serotonin re-uptake transporter mRNA expression by ovarian steroids in rhesus macaques. Brain Res Mol Brain Res 53(1–2):120–129PubMedCrossRef

Peter I, Kelley-Hedgepeth A, Huggins GS, Housman DE, Mendelsohn ME, Vita JA, Vasan RS, Levy D, Benjamin EJ, Mitchell GF (2009) Association between arterial stiffness and variations in oestrogen-related genes. J Hum Hypertens 23(10):636–644. doi:10.1038/jhh.2009.1 jhh20091 PubMedCrossRef

Pinsonneault J, Papp A, Sadee W (2006) Allelic expression of monoamine oxidase A (MAOA) in human brain: Evidence for cis-acting genetic and epigenetic factors. Hum Mol Gen 15(17):2636–2649PubMedCrossRef

Pinsonneault JK, Han DD, Burdick KE, Kataki M, Bertolino A, Malhotra AK, Gu HH, Sadee W (2011) Dopamine transporter gene variant affecting expression in human brain is associated with bipolar disorder. Neuropsychopharmacology 36(8):1644–1655. doi:10.1038/npp.2011.45 npp201145 PubMedCrossRef

Ryan J, Scali J, Carriere I, Peres K, Rouaud O, Scarabin PY, Ritchie K, Ancelin ML (2011) Oestrogen receptor polymorphisms and late-life depression. Br J Psychiatry 199(2):126–131. doi:10.1192/bjp.bp.111.091751 PubMedCrossRef

Ryan J, Scali J, Carriere I, Peres K, Rouaud O, Scarabin PY, Ritchie K, Ancelin ML (2012) Estrogen receptor alpha gene variants and major depressive episodes. J Affect Disord 136(3):1222–1226. doi:10.1016/j.jad.2011.10.010 PubMedCrossRef

Sanjuan J, Martin-Santos R, Garcia-Esteve L, Carot JM, Guillamat R, Gutierrez-Zotes A, Gornemann I, Canellas F, Baca-Garcia E, Jover M, Navines R, Valles V, Vilella E, de Diego Y, Castro JA, Ivorra JL, Gelabert E, Guitart M, Labad A, Mayoral F, Roca M, Gratacos M, Costas J, van Os J, de Frutos R (2008) Mood changes after delivery: role of the serotonin transporter gene. Br J Psychiatry 193(5):383–388. doi:10.1192/bjp.bp.107.045427 PubMedCrossRef

Sano M, Inoue S, Hosoi T, Ouchi Y, Emi M, Shiraki M, Orimo H (1995) Association of estrogen receptor dinucleotide repeat polymorphism with osteoporosis. Biochem Biophys Res Commun 217(1):378–383. doi:10.1006/bbrc.1995.2787 PubMedCrossRef

Scheid JM, Holzman CB, Jones N, Friderici KH, Nummy KA, Symonds LL, Sikorskii A, Regier MK, Fisher R (2007) Depressive symptoms in mid-pregnancy, lifetime stressors and the 5-HTTLPR genotype. Genes Brain Behav 6(5):453–464. doi:10.1111/j.1601-183X.2006.00272 PubMedCrossRef

Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC (1998) The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59(Suppl 20):22–33, quiz 34–57PubMed

Smith RM, Papp AC, Webb A, Ruble CL, Munsie LM, Nisenbaum LK, Kleinman JE, Lipska BK, Sadee W (2012) Multiple Regulatory Variants Modulate Expression of 5-Hydroxytryptamine 2A Receptors in Human Cortex. Biol Psychiatry. doi:S0006-3223(12)00854-2 [pii] 10.1016/j.biopsych.2012.09.028

Spitzer RL, Williams JB, Gibbon M, First MB (1992) The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description. Arch Gen Psychiatry 49(8):624–629PubMedCrossRef

Stahl S (2001) Effects of estrogen on the central nervous system. J Clin Psychiatry 62:317–318PubMedCrossRef

Steiner M (1998) Perinatal mood disorders: position paper. Psychopharmacol Bull 34:301–306PubMed

Steiner M, Dunn E, Born L (2003) Hormones and mood: from menarche to menopause and beyond. J Affect Disord 74(1):67–83PubMedCrossRef

Sun HS, Tsai HW, Ko HC, Chang FM, Yeh TL (2004) Association of tryptophan hydroxylase gene polymorphism with depression, anxiety and comorbid depression and anxiety in a population-based sample of postpartum Taiwanese women. Genes Brain Behav 3(6):328–336PubMedCrossRef

Treloar SA, Martin NG, Bucholz KK, Madden PA, Heath AC (1999) Genetic influences on post-natal depressive symptoms: findings from an Australian twin sample. Psychol Med 29(3):645–654PubMedCrossRef

Tye KM, Mirzabekov JJ, Warden MR, Ferenczi EA, Tsai HC, Finkelstein J, Kim SY, Adhikari A, Thompson KR, Andalman AS, Gunaydin LA, Witten IB, Deisseroth K (2013) Dopamine neurons modulate neural encoding and expression of depression-related behaviour. Nature 493(7433):537–541. doi:10.1038/nature11740 nature11740 PubMedCrossRef

Xie L, Innis SM (2009) Association of fatty acid desaturase gene polymorphisms with blood lipid essential fatty acids and perinatal depression among Canadian women: a pilot study. J Nutrigenet Nutrigenomics 2(4–5):243–250. doi:10.1159/000255636 PubMedCrossRef

Yu YW, Tsai SJ, Chen TJ, Lin CH, Hong CJ (2002) Association study of the serotonin transporter promoter polymorphism and symptomatology and antidepressant response in major depressive disorders. Mol Psychiatry 7(10):1115–1119PubMedCrossRef

Zhang Y, Bertolino A, Fazio L, Blasi G, Rampino A, Romano R, Lee M, Xiao T, Papp A, Wang D, Sadée W (2007) Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory. Proc Natl Acad Sci U S A 104(51):20552–20557PubMedCrossRef

Zill P, Engel R, Baghai TC, Juckel G, Frodl T, Muller-Siecheneder F, Zwanzger P, Schule C, Minov C, Behrens S, Rupprecht R, Hegerl U, Moller HJ, Bondy B (2002) Identification of a naturally occurring polymorphism in the promoter region of the norepinephrine transporter and analysis in major depression. Neuropsychopharmacology 26(4):489–493PubMedCrossRef

Titel: Association study of the estrogen receptor gene ESR1 with postpartum depression—a pilot study
verfasst von: Julia K. Pinsonneault
Danielle Sullivan
Wolfgang Sadee
Claudio N. Soares
Elizabeth Hampson
Meir Steiner
Publikationsdatum: 01.12.2013
Verlag: Springer Vienna
Erschienen in: Archives of Women's Mental Health / Ausgabe 6/2013
Print ISSN: 1434-1816
Elektronische ISSN: 1435-1102
DOI: https://doi.org/10.1007/s00737-013-0373-8

Neu in den Fachgebieten Neurologie und Psychiatrie

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Delir bei kritisch Kranken – Antipsychotika versus Placebo

16.05.2024 Delir Nachrichten

Um die Langzeitfolgen eines Delirs bei kritisch Kranken zu mildern, wird vielerorts auf eine Akuttherapie mit Antipsychotika gesetzt. Eine US-amerikanische Forschungsgruppe äußert jetzt erhebliche Vorbehalte gegen dieses Vorgehen. Denn es gibt neue Daten zum Langzeiteffekt von Haloperidol bzw. Ziprasidon versus Placebo.

Schwindelursache: Massagepistole lässt Otholiten tanzen

14.05.2024 Benigner Lagerungsschwindel Nachrichten

Wenn jüngere Menschen über ständig rezidivierenden Lagerungsschwindel klagen, könnte eine Massagepistole der Auslöser sein. In JAMA Otolaryngology warnt ein Team vor der Anwendung hochpotenter Geräte im Bereich des Nackens.

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Association study of the estrogen receptor gene ESR1 with postpartum depression—a pilot study

Abstract

Neu in den Fachgebieten Neurologie und Psychiatrie

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

ADHS-Medikation erhöht das kardiovaskuläre Risiko

Delir bei kritisch Kranken – Antipsychotika versus Placebo

Schwindelursache: Massagepistole lässt Otholiten tanzen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2013

Elevated risk of adverse obstetric outcomes in pregnant women with depression

Maternal anxiety disorders prior to conception, psychopathology during pregnancy and early infants’ development: a prospective-longitudinal study

The EPDS-Lifetime: assessment of lifetime prevalence and risk factors for perinatal depression in a large cohort of depressed women

Changes in PTSD symptomatology and mental health during pregnancy and postpartum

Influence of health information levels on postpartum depression

Erratum to: Influence of health information levels on postpartum depression

Neu in den Fachgebieten Neurologie und Psychiatrie

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

ADHS-Medikation erhöht das kardiovaskuläre Risiko

Delir bei kritisch Kranken – Antipsychotika versus Placebo

Schwindelursache: Massagepistole lässt Otholiten tanzen